Discover
VIR
Vir Biotechnology, Inc.
8.93
1 x 8.80
1 x 9.12
bid
ask
+
0.04
0.45%
2 @ 04:00 PM
8.90 -0.03 (0.34%)
| Ytd | 48.09% | |
| 1y | 108.64% |
8.77
day range
9.01
4.25
52 week range
11.66
| Open | 8.96 | Prev Close | 8.89 | Low | 8.77 | High | 9.01 | Mkt Cap | 1.51B |
| Vol | 0.00 | Avg Vol | 1.86M | EPS | -1.86 | P/E | -4.80 | Forward P/E | -3.33 |
| Beta | 1.59 | Short Ratio | 7.83 | Inst. Own | 85.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 9.28 | 200-d Avg | 8.15 | 1yr Est | 21.00 |
| Income Statement | |||
| Total Revenue | 238.95M | ||
| Revenues (USD) | 238.95M | ||
| Gross Profit | 238.95M | ||
| Operating Expenses | 165.48M | ||
| Research and Development Expense | 135.28M | ||
| Selling, General and Administrative Expense | 30.20M | ||
| Operating Income | 73.47M | ||
| Income Tax Expense | 179.00K | ||
| Net Income | 80.08M | ||
| Net Income Common Stock | 80.08M | ||
| Net Income Common Stock (USD) | 80.08M | ||
| Consolidated Income | 80.08M | ||
| Earnings per Basic Share | 0.48 | ||
| Earnings per Basic Share (USD) | 0.48 | ||
| Earnings per Diluted Share | 0.47 | ||
| Earning Before Interest & Taxes (EBIT) | 80.26M | ||
| Earning Before Interest & Taxes (USD) | 80.26M | ||
| Weighted Average Shares | 167.72M | ||
| Weighted Average Shares Diluted | 168.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 280.66M | ||
| Cash and Equivalents (USD) | 280.66M | ||
| Investments | 735.96M | ||
| Investments Current | 254.00M | ||
| Investments Non-Current | 481.96M | ||
| Current Assets | 573.74M | ||
| Property, Plant & Equipment Net | 109.82M | ||
| Total Assets | 1.21B | ||
| Total Debt | 84.14M | ||
| Current Liabilities | 94.96M | ||
| Debt Non-Current | 84.14M | ||
| Total Liabilities | 232.31M | ||
| Accumulated Retained Earnings (Deficit) | -1.24B | ||
| Accumulated Other Comprehensive Income | -4.60M | ||
| Shareholders Equity | 982.49M | ||
| Shareholders Equity (USD) | 982.49M | ||
| Assets Non-Current | 641.07M | ||
| Total Debt (USD) | 84.14M | ||
| Goodwill and Intangible Assets | 24.64M | ||
| Liabilities Non-Current | 137.35M | ||
| Trade and Non-Trade Payables | 17.75M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.17M | ||
| Net Cash Flow from Financing | 78.38M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.56M | ||
| Capital Expenditure | -32.00K | ||
| Issuance (Purchase) of Equity Shares | 78.38M | ||
| Net Cash Flow from Investing | -197.14M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -197.11M | ||
| Net Cash Flow from Operations | 123.33M | ||
| Share Based Compensation | 12.39M | ||